Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 116.6
2 %
$ 145 B
Market Cap
25.29
P/E
Price Target
Average
--27.19%
Revenue Forecast
Estimate
3.68%
EBIT
Estimate
49.72%
Net Income
Estimate
126.12%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Gilead Sciences, Inc.
Wall Street analysts predict an average 1-year price target for GILD of $84.9 , with forecasts ranging from
a
low of
$69 to a high of $105 .
GILD Lowest Price Target
Wall Street Target
69 USD
-40.82%
GILD Average Price Target
Wall Street Target
84.9 USD
-27.19%
GILD Highest Price Target
Wall Street Target
105 USD
-9.95%
REVENUE FORECAST
Revenue Forecast Chart GILD
EBIT FORECAST
EBIT Forecast Chart GILD
NET INCOME FORECAST
Net Income Chart GILD